Key points are not available for this paper at this time.
A substantial proportion of patients diagnosed with CHP have rare, protein-altering variants in telomere-related genes, which are associated with short peripheral blood telomere length and significantly reduced transplant-free survival.
Ley et al. (Wed,) studied this question.